When was Respyre founded?

Respyre was founded in 2019 and raised its 1st funding round 4 years after it was founded.

Where is Respyre located?

Respyre is headquartered in Delft, Netherlands.

How many employees does Respyre have?

As of Jul 01, 2024, the latest employee count at Respyre is 3.

Is Respyre a funded company?

Respyre is a funded company, having raised a total of $319K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 03, 2023.

When was the latest funding round of Respyre?

Respyre's latest funding was a $***** Grant (prize money) round on Nov 22, 2024, with participation from 0 investor.

Where does Respyre rank among its competitors?

Respyre ranks 5th amongst 5 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Respyre, which secured $10.5K in Nov, 2024.

Who are the top competitors of Respyre?

Respyre's top competitors include ECOncrete, Tattva and Biocement. Among them, Respyre secured the most recent funding round in November, 2024.

Respyre - 2026 Company Profile, Funding & Competitors

Company Details

{}

Website: gorespyre.com
Social
Email ID: *****@GoRespyre.com

Key Metrics

Founded Year

2019

Location

Delft, Netherlands

Stage

Seed

Total Funding

$319K in 2 rounds

Latest Funding Round

Grant (prize money), Nov 22, 2024, $*****

Investors

Innovatiefonds Noord-Holland & 2 more

Ranked

5^th among 5 active competitors

Employee Count

3 as on Jul 01, 2024

Similar Companies

Tattva & 1 more

View Respyre's full profile

Respyre has raised a total funding of $319K over 2 rounds. Its first funding round was on Mar 03, 2023. Respyre has 3 institutional investors.

Here is the list of recent funding rounds of Respyre:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 22, 2024	4152444	Grant (prize money)	9775249	5048034	3427948	7919050
Mar 03, 2023	1606205	Seed	4956541	5189139	Innovatiefonds Noord-Holland	9084312

Access funding benchmarks and valuations. Sign up today!

View details of Respyre's funding rounds and investors

Respyre's employee count trend

Respyre has 3 employees as of Jul 24. Here is Respyre's employee count trend over the years:

Uncover Respyre's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Respyre include ECOncrete, Tattva and Biocement. Here is the list of Top 10 competitors of Respyre, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ECOncrete 2012, Tel Aviv (Israel), Series A	Provider of eco-friendly bio-enhancing concrete products for the construction industry	$10M	Bridges Israel, 8200 EISP & 9 others	47/100
2nd	Tattva 2022, London (United Kingdom), Unfunded	Organization developing innovative biological construction systems	-	-	29/100
3rd	Biocement 2014, Seattle (United States), Seed	Provider of bio-based cement materials	$252K	HHS	25/100
4th	The Living 2005, New York City (United States), Acqui-Hired	Provider of bio design solutions for constructing buildings	-	-	24/100
5th	Respyre 2019, Delft (Netherlands), Seed	Developer of bioreceptive concrete and moss-based green wall systems. These systems improve air quality, reduce urban heat island effects, and create ecological habitats. The company offers solutions for new construction and renovation projects, utilizing a bioreceptive concrete that supports moss growth on vertical surfaces. Pre-fabricated panels are also available for seamless integration into building designs. The technology is low-maintenance and promotes sustainable urban development.	$319K	Innovatiefonds Noord-Holland, Delft Enterprises ... & 1 others	24/100
6th	Grow Oyster Reefs 2015, Charlottesville (United States), Funding Raised	Manufacturer of tiles, concrete reef tangle and other building materials	-	National Science Foundation	21/100